2005, Número 2
<< Anterior Siguiente >>
Ann Hepatol 2005; 4 (2)
Incidence and prevalence of hepatitis C virus infection in Chile
González R, Soza A, Hernández V, Pérez RM, Álvarez M, Morales A, Arellano M, Riquelme A, Viviani P, Covarrubias C, Arrese M, Miquel JF, Nervi F
Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 127-130
Archivo PDF: 72.69 Kb.
FRAGMENTO
Sin resumen
REFERENCIAS (EN ESTE ARTÍCULO)
Brown RS Jr, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl 2003; 9: S10-13.
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.
Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9: 84-100.
Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.
Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687-1695.
Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296-305.
Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997; 112: 651-655.
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
Rakela J, Vargas HE. Hepatitis C: magnitude of the problem. Liver Transpl 2002; 8: S3-6.
Buckel E, Uribe M, Brahm J, Silva G, Ferrario M, Godoy J, Segovia R, et al. Outcomes of orthotopic liver transplantation in Chile. Transplant Proc 2003; 35: 2509-2510.
Covarrubias C, Chianale J, Aldunce M. Detection of antibody to hepatitis C virus in Chilean blood donors, patient with chronic liver disease and high risk subjects. Gastroenterology 1998; 115: A577.
Wolff C, Jiron MI, Elgueta R, Vera M, Toriello L, Martinez L, Parraguez A. Prevalence of antibody to hepatitis C virus in blood donors. Analysis of confirmed results. Rev Med Chil 1996; 124: 615-616.
Munoz G, Velasco M, Thiers V, Hurtado C, Brahm J, Larrondo-Lillo M, Guglielmetti A, et al. Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population. Rev Med Chil 1998; 126: 1035-1042.
Gonzalez R, Vollrath V, Pereira J, Covarrubias C, Vacarezza A, Chianale J. Prevalence of hepatitis C virus RNA in hemodialysis patients: comparison of four antibody assays. Nephron 1995; 69: 181-182.
Quero MS, Suarez M, Munoz G, Torres M, Pena M. Prevalence of hepatitis C virus antibodies in pregnant women in Santiago. Rev Med Chil 1995; 123: 907-908.
Wolff C, Armas R, Puig A, Krause P, Parraguez A. Hepatitis C virus infection in patients with porphyria. Rev Med Chil 1994; 122: 294-298.
Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937-946.
Matson GA, Sutton HE, Etcheverry RB, Swanson J, Robinson A. Distribution of hereditary blood groups among Indians in South America. 1970; 27: 157-194.
Chakaraborty R. Gene admixture in human populations, models and predictions. Yearbook Phys Anthropol 1986; 29: 1-43.
Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
Horai S, Kondo R, Nakagawa-Hattori Y, Hayashi S, Sonoda S, Tajima K. Peopling of the Americas, founded by four major lineages of mitochondrial DNA. Mol Biol Evol 1993; 10: 23-47.
Ginther C, Corach D, Penacino GA, Rey JA, Carnese FR, Hutz MH, Anderson A, et al. Genetic variation among the Mapuche Indians from the Patagonian region of Argentina: mitochondrial DNA sequence variation and allele frequencies of several nuclear genes. In: Pena SDJ, Chakraborty R, Epplen JT, Jeffreys AJ, eds. DNA fingerprinting: state of the science. Basel: Birkhauser Verlag, 1993: 214-219.
Hepatitis C - Global prevalence (update). Wkly Epidemiol Rec 1999; 74: 425-427.
Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. Jama 1996; 275: 995-1000.
Soza A, Arrese M, Gonzalez R, Alvarez M, Perez RM, Cortes P, Patillo A, et al. Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C. Ann Hepatol 2004; 3: 146-151.
Centers for Disease Control and Prevention. Estimated Incidence of Acute HCV Infection United States, 1960-2001. http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_c/hcv_epi_for_distrib_000925.ppt 2003.